163 related articles for article (PubMed ID: 27584024)
1. Role of salvage lymph node dissection in prostate cancer.
Heidenreich A; Moul JW; Shariat S; Karnes RJ
Curr Opin Urol; 2016 Nov; 26(6):581-9. PubMed ID: 27584024
[TBL] [Abstract][Full Text] [Related]
2. A comprehensive review of contemporary role of local treatment of the primary tumor and/or the metastases in metastatic prostate cancer.
Aoun F; Peltier A; van Velthoven R
Biomed Res Int; 2014; 2014():501213. PubMed ID: 25485280
[TBL] [Abstract][Full Text] [Related]
3. Metastasis-directed therapy and prostate-targeted therapy in oligometastatic prostate cancer: a systematic review.
Miura N; Pradere B; Mori K; Mostafaei H; Quhal F; Misrai V; D'Andrea D; Albisinni S; Papalia R; Saika T; Scarpa RM; Shariat SF; Esperto F
Minerva Urol Nefrol; 2020 Oct; 72(5):531-542. PubMed ID: 32550632
[TBL] [Abstract][Full Text] [Related]
4. Role of RPLND and Metastasectomy in the Management of Oligometastatic Renal Cell Carcinoma.
Nagaraja H; Srivatsa N; Hemalatha S; Shweta S; Raghunath SK
Indian J Surg Oncol; 2018 Mar; 9(1):105-109. PubMed ID: 29563747
[TBL] [Abstract][Full Text] [Related]
5. De-Escalation of Therapy for Prostate Cancer.
Esen T; Esen B; Yamaoh K; Selek U; Tilki D
Am Soc Clin Oncol Educ Book; 2024 Jan; 44(2):e430466. PubMed ID: 38206291
[TBL] [Abstract][Full Text] [Related]
6. Oligometastatic Prostate Cancer-The Middle Child Syndrome.
Lim EJ; Su M; Saiduzzaman BM; Tay KJ; Ho HSS; Tokas T; Somani BK; Gauhar V; Yuen JSP; Chen K
J Clin Med; 2023 Nov; 12(23):. PubMed ID: 38068251
[TBL] [Abstract][Full Text] [Related]
7. Enzalutamide in castration-resistant prostate cancer patients with visceral disease in the liver and/or lung: Outcomes from the randomized controlled phase 3 AFFIRM trial.
Loriot Y; Fizazi K; de Bono JS; Forer D; Hirmand M; Scher HI
Cancer; 2017 Jan; 123(2):253-262. PubMed ID: 27648814
[TBL] [Abstract][Full Text] [Related]
8. The association between sexual function and prostate cancer risk in US veterans.
Zapata DF; Howard LE; Frank J; Simon RM; Hoyo C; Grant DJ; Freedland SJ; Vidal AC
Asian J Androl; 2017; 19(2):191-195. PubMed ID: 27586025
[TBL] [Abstract][Full Text] [Related]
9. EAU-ESTRO-SIOG Guidelines on Prostate Cancer. Part II: Treatment of Relapsing, Metastatic, and Castration-Resistant Prostate Cancer.
Cornford P; Bellmunt J; Bolla M; Briers E; De Santis M; Gross T; Henry AM; Joniau S; Lam TB; Mason MD; van der Poel HG; van der Kwast TH; Rouvière O; Wiegel T; Mottet N
Eur Urol; 2017 Apr; 71(4):630-642. PubMed ID: 27591931
[TBL] [Abstract][Full Text] [Related]
10. Impact of
Bluemel C; Linke F; Herrmann K; Simunovic I; Eiber M; Kestler C; Buck AK; Schirbel A; Bley TA; Wester HJ; Vergho D; Becker A
EJNMMI Res; 2016 Dec; 6(1):78. PubMed ID: 27785766
[TBL] [Abstract][Full Text] [Related]
11. Pathological analysis of the prostatic anterior fat pad at radical prostatectomy: insights from a prospective series.
Ball MW; Harris KT; Schwen ZR; Mullins JK; Han M; Walsh PC; Partin AW; Epstein JI
BJU Int; 2017 Mar; 119(3):444-448. PubMed ID: 27611825
[TBL] [Abstract][Full Text] [Related]
12. Predictive Parameters Identifying Men Eligible for a Sole MRI/Ultrasound Fusion-Guided Targeted Biopsy without an Additional Systematic Biopsy.
Günzel K; Haas M; Maxeiner A; Stephan C; Buckendahl J; Asbach P; Miller K; Kempkensteffen C; Cash H
Urol Int; 2017; 98(1):15-21. PubMed ID: 27618633
[TBL] [Abstract][Full Text] [Related]
13. Very Early Salvage Radiotherapy Improves Distant Metastasis-Free Survival.
Abugharib A; Jackson WC; Tumati V; Dess RT; Lee JY; Zhao SG; Soliman M; Zumsteg ZS; Mehra R; Feng FY; Morgan TM; Desai N; Spratt DE
J Urol; 2017 Mar; 197(3 Pt 1):662-668. PubMed ID: 27614333
[TBL] [Abstract][Full Text] [Related]
14. Assessing Metastatic Disease in Advanced Prostate Cancer: It's Time to Change Imaging.
Barentsz JO; Mulders P; Gerritsen W; Fütterer JJ
Eur Urol; 2017 Jan; 71(1):93-95. PubMed ID: 27595376
[No Abstract] [Full Text] [Related]
15. Assessing the Educational Needs of Urologists Managing Patients With Castration-Resistant Prostate Cancer: A Multiyear Study.
Barlett MM; Carrick TA; Lowrance WT; Freedland SJ
J Contin Educ Health Prof; 2016; 36 Suppl 1():S42-3. PubMed ID: 27584069
[No Abstract] [Full Text] [Related]
16. Robot-assisted Salvage Lymph Node Dissection for Clinically Recurrent Prostate Cancer.
Montorsi F; Gandaglia G; Fossati N; Suardi N; Pultrone C; De Groote R; Dovey Z; Umari P; Gallina A; Briganti A; Mottrie A
Eur Urol; 2017 Sep; 72(3):432-438. PubMed ID: 27600589
[TBL] [Abstract][Full Text] [Related]
17. Temporal Trends and the Impact of Race, Insurance, and Socioeconomic Status in the Management of Localized Prostate Cancer.
Gray PJ; Lin CC; Cooperberg MR; Jemal A; Efstathiou JA
Eur Urol; 2017 May; 71(5):729-737. PubMed ID: 27597241
[TBL] [Abstract][Full Text] [Related]
18. Early Postoperative Radiotherapy is Associated with Worse Functional Outcomes in Patients with Prostate Cancer.
Zaffuto E; Gandaglia G; Fossati N; Dell'Oglio P; Moschini M; Cucchiara V; Suardi N; Mirone V; Bandini M; Shariat SF; Karakiewicz PI; Montorsi F; Briganti A
J Urol; 2017 Mar; 197(3 Pt 1):669-675. PubMed ID: 27670915
[TBL] [Abstract][Full Text] [Related]
19. Association between lifetime alcohol consumption and prostate cancer risk: A case-control study in Montreal, Canada.
Demoury C; Karakiewicz P; Parent ME
Cancer Epidemiol; 2016 Dec; 45():11-17. PubMed ID: 27664387
[TBL] [Abstract][Full Text] [Related]
20. Meat, Fish, Poultry, and Egg Intake at Diagnosis and Risk of Prostate Cancer Progression.
Wilson KM; Mucci LA; Drake BF; Preston MA; Stampfer MJ; Giovannucci E; Kibel AS
Cancer Prev Res (Phila); 2016 Dec; 9(12):933-941. PubMed ID: 27651069
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
